These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30967832)

  • 21. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
    Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trajectories of prediagnostic functioning in Parkinson's disease.
    Darweesh SK; Verlinden VJ; Stricker BH; Hofman A; Koudstaal PJ; Ikram MA
    Brain; 2017 Feb; 140(2):429-441. PubMed ID: 28082300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two motor subtype classifications in de novo Parkinson's disease.
    Choi SM; Kim BC; Cho BH; Kang KW; Choi KH; Kim JT; Lee SH; Park MS; Kim MK; Cho KH
    Parkinsonism Relat Disord; 2018 Sep; 54():74-78. PubMed ID: 29703644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
    Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
    Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia.
    Kipfer S; Stephan MA; Schüpbach WM; Ballinari P; Kaelin-Lang A
    Arch Neurol; 2011 Aug; 68(8):1037-9. PubMed ID: 21825240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
    Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease.
    Martínez-Martín P; Hernández B; Ricart J;
    Neurologia; 2014 Apr; 29(3):153-60. PubMed ID: 23465686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
    Frau R; Savoia P; Fanni S; Fiorentini C; Fidalgo C; Tronci E; Stancampiano R; Meloni M; Cannas A; Marrosu F; Bortolato M; Devoto P; Missale C; Carta M
    Exp Neurol; 2017 May; 291():1-7. PubMed ID: 28131725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?
    Chung SJ; Yoo HS; Lee HS; Lee PH; Sohn YH
    J Parkinsons Dis; 2019; 9(1):241-247. PubMed ID: 30741690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A rapid detection of motor block in patients with Parkinson disease during volitional movements of the hand].
    Popović MB; Kostić V; Dzoljić E; Ercegovac M
    Srp Arh Celok Lek; 2002; 130(11-12):376-81. PubMed ID: 12751160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease.
    Mann RK; Edwards R; Zhou J; Jog M; Duval C
    Clin Neurol Neurosurg; 2010 Jun; 112(5):392-9. PubMed ID: 20206438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An automated methodology for levodopa-induced dyskinesia: assessment based on gyroscope and accelerometer signals.
    Tsipouras MG; Tzallas AT; Rigas G; Tsouli S; Fotiadis DI; Konitsiotis S
    Artif Intell Med; 2012 Jun; 55(2):127-35. PubMed ID: 22484102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
    Bartels AL; Balash Y; Gurevich T; Schaafsma JD; Hausdorff JM; Giladi N
    J Clin Neurosci; 2003 Sep; 10(5):584-8. PubMed ID: 12948464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
    Ory-Magne F; Corvol JC; Azulay JP; Bonnet AM; Brefel-Courbon C; Damier P; Dellapina E; Destée A; Durif F; Galitzky M; Lebouvier T; Meissner W; Thalamas C; Tison F; Salis A; Sommet A; Viallet F; Vidailhet M; Rascol O;
    Neurology; 2014 Jan; 82(4):300-7. PubMed ID: 24371304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of bilateral subthalamic deep brain stimulation for Parkinson's disease.
    Zhang JG; Zhang K; Ma Y; Hu WH; Yang AC; Chu JS; Wu ST; Ge M; Zhang Y; Wang ZC
    Acta Neurochir Suppl; 2006; 99():43-7. PubMed ID: 17370762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring Motor Symptoms During Activities of Daily Living in Individuals With Parkinson's Disease.
    Thorp JE; Adamczyk PG; Ploeg HL; Pickett KA
    Front Neurol; 2018; 9():1036. PubMed ID: 30619024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia.
    Zhang YH; Tang BS; Song CY; Xu Q; Lou MX; Liu ZH; Yu RH; Yan XX; Guo JF
    Neurosci Lett; 2013 Nov; 556():109-12. PubMed ID: 24135335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of an association between sleep and levodopa-induced dyskinesia in an animal model of Parkinson's disease.
    Galati S; Salvadè A; Pace M; Sarasso S; Baracchi F; Bassetti CL; Kaelin-Lang A; Städler C; Stanzione P; Möller JC
    Neurobiol Aging; 2015 Mar; 36(3):1577-89. PubMed ID: 25596726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.